GlaxoSmithKline Biologicals

news

First RSV vaccine approved for older adults

4 May 2023 | By Catherine Eckford (European Pharmaceutical Review)

The US Food and Drug Administration (FDA) has approved the first-ever vaccine for respiratory syncytial virus (RSV) in adults over 60 years old.

news

First FDA pregnancy-approved Pertussis vaccine to protect newborns

10 October 2022 | By Catherine Eckford (European Pharmaceutical Review)

The FDA has approved Boostrix, the first vaccine for pregnant women in their third trimester, to stop whooping cough (Pertussis) in infants below two months.